Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Findings explain higher risk of heart attack in people with diabetes, even after treatment .

Jars of sweets, with red, heart-shaped candies in the foreground

High levels of glucose in the blood ‘reprogrammes’ stem cells, leading to a lasting increase in the risk of developing dangerous atherosclerosis, according to research led by Professor Robin Choudhury

Radcliffe Department of Medicine researchers found that high blood glucose, a hallmark of diabetes, alters stem cells in the bone marrow that go on to become white blood cells called macrophages. As a result, these macrophages become inflammatory and contribute to the development of atherosclerotic plaques that can cause heart attacks.

This finding explains why people with diabetes are at increased risk of heart attack, even after their blood glucose levels are brought back under control, a paradox that has troubled doctors for years.

Nearly five million people in the UK have diabetes1, and adults with the condition have double the risk of having a heart attack.2. These findings open new possibilities for treatments that could reduce the risk of heart and circulatory disease in people with diabetes.

The team investigated the differences in white blood cells in people with and without type 2 diabetes. They removed the white blood cells from blood samples and grew them in an environment with normal glucose levels. Those from people with type 2 diabetes showed a greatly exaggerated inflammatory response compared to the cells from people without the condition.

Researchers also extracted stem cells from the bone marrow of mice with and without diabetes and transplanted these into mice with normal blood glucose levels. The bone marrow taken from diabetic mice ‘remembered’ its exposure to high levels of glucose and as a result the mice receiving this bone marrow developed almost double the amount of atherosclerotic plaques.

When the team looked at the mouse macrophages in more detail they found that those that had developed from stem cells in the bone marrow of diabetic mice had been permanently altered to become more inflammatory.

The team now want to explore new avenues for treatments based on this finding. They also want to find out whether short periods of increased blood glucose in people without diabetes have this damaging effect.

Professor Robin Choudhury, Professor of Cardiovascular Medicine at the Radcliffe Department of Medicine, University of Oxford, led the research. He said “Our study is the first to show that diabetes causes long-term changes to the immune system, and how this might account for the sustained increase in the risk of heart attack.

We need to change the way we think about, and treat, diabetes. By focussing too narrowly on a managing a person’s blood sugar levels we’re only addressing part of the problem.
- Professor Robin Choudhury

“Right now, people with diabetes aren’t receiving effective treatment for their increased risk of heart and circulatory disease. These findings identify new opportunities for preventing and treating the complications of diabetes.”
Professor Sir Nilesh Samani, Medical Director at the British Heart Foundation, which funded the research, said:
“While treatments for diabetes have improved, people with diabetes still have a higher risk of heart attacks. This research may provide part of the explanation for why this is the case and potentially pave the way for new treatments to reduce the risk of heart attack for the millions of people living with diabetes.”

This research was also funded by the Tripartite Immunometabolism Consortium (TrIC) – Novo Nordisk Foundation.

Read the full paper

Text courtesy of BHF. 

Similar stories

Joaquim Vieira brings heart regeneration research to the public at Pint of Science

Pint of Science is the world’s largest public science festival bringing researchers to local pubs, cafes and spaces to share their scientific discoveries with the public.

DPAG researchers showcased at premier European Society of Cardiology meeting

DPAG scientists across four research groups were highlighted at the major annual European Society of Cardiology basic science conference (FCVB 2022). Congratulations are in order for Dr KC Park on receiving the Young Investigator Award and to Dr Elisabetta Gamen on winning the Moderated Poster Prize.

RDM researchers awarded £2million MRC grant

Researchers at the Cardiovascular Clinical Research Facility (CCRF) have won a five year MRC funding programme to help understand how high blood pressure (hypertension) during pregnancy affects the heart, brain and blood vessels throughout the life of women, as well as the children born after such a pregnancy.

Study indicates reasons for decline in death rates from heart attacks

A new study involving Oxford Population Health researchers finds that both prevention and improved treatments have helped reduce deaths from heart attacks - but the relative importance of each varies by country, age and sex.

Commercial development of therapeutic anti-inflammatory peptide begins

An Oxford BHF CRE “Pump Priming” award to Professor Shoumo Bhattacharya and his research group led to a great return on investment with this exclusive licensing agreement for their innovative research.

Dr Qiang Zhang wins Society for Cardiovascular Magnetic Resonance Early Career Award 2022

Many congratulations to Dr Qiang Zhang, Oxford BHF CRE Transition Fellow, who has won a prestigious award for his work in developing a groundbreaking technology for detecting scar in the myocardium